Special Letter of Thanks to the Lymphoma Canada Scientific Advisory Board

By April 28, 2021No Comments

Lymphoma Canada would like to express our heartfelt thanks and gratitude to our Scientific Advisory Board (SAB), comprised of outstanding leaders in hematology and oncology specialities across Canada. In a year affected by an unprecedented pandemic, the dedication of Lymphoma Canada’s SAB has been more pronounced than ever. They have provided support and guidance for lymphoma patients regarding COVID-19 and the vaccines in addition to continued efforts to develop educational materials, programs, policies, and guidelines. We thank you for your unwavering support through both your work with our organization and your daily clinical practice. Lymphoma Canada could not accomplish as much without the support of these exceptional professionals from the medical community. We would like to thank the following individuals and members of our current Scientific Advisory Board:

Dr. John Kuruvilla (Princess Margaret Hospital, Ontario), SAB Chair

Dr. David MacDonald (The Ottawa Hospital, Ontario)

Dr. Graeme Fraser (Juravinski Cancer Centre, Ontario)

Dr. Douglas Stewart (Tom Baker Cancer Centre, Alberta)

Dr. Tony Reiman (Saint John Regional Hospital, New Brunswick)

Dr. Kerry Savage (BC Cancer Agency, British Columbia)

Dr. David Hodgson (Princess Margaret Hospital, Ontario)

Dr. Isabelle Bence-Bruckler (The Ottawa Hospital, Ontario)

Dr. Jean-Francois Larouche (Centre hospitalier affilié universitaire de Québec, Quebec)

Dr. Mark Bosch (Saskatchewan Cancer Agency, Saskatchewan)

Dr. Joanne Hickey (Memorial University, Newfoundland and Labrador)

Dr. Pamela Skrabek (CancerCare Manitoba, Manitoba)


History of the Scientific Advisory Board with Lymphoma Canada

The Lymphoma Canada Scientific Advisory Board consists of a volunteer group of scientists and clinicians distinguished in fields related to lymphoid cancer research and clinical care. The SAB is an integral part of Lymphoma Canada and provides advice and guidance on clinical care and research related programs, patient education activities and resources, public policy and advocacy activities, and research grants and programs. The SAB has been established as an integral part of Lymphoma Canada for many years. We would therefore like to also extend our thanks to past members of the Scientific Advisory Board.


About laurad